1,954
Participants
Start Date
June 1, 2007
Primary Completion Date
September 1, 2011
Study Completion Date
March 1, 2016
Taking of blood samples
No treatment is planned to be given in this study. Blood samples will be collected at the following time points: 1 year, 3 years, 5 years and 9 years after the dose of vaccination.
Boostrix
A single dose of Boostrix was administered in the primary study (NCT00346073). No treatment was given in this study.
Adacel
A single dose of Adacel was administered in the primary study (NCT00346073). No treatment was given in this study.
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Johnstown
GSK Investigational Site, Grove City
GSK Investigational Site, Erie
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Norfolk
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Raleigh
GSK Investigational Site, Tabor City
GSK Investigational Site, Charleston
GSK Investigational Site, Melbourne
GSK Investigational Site, Pembroke Pines
GSK Investigational Site, Miami
GSK Investigational Site, Huntsville
GSK Investigational Site, Bristol
GSK Investigational Site, Bardstown
GSK Investigational Site, South Bend
GSK Investigational Site, Richland
GSK Investigational Site, Peoria
GSK Investigational Site, St Louis
GSK Investigational Site, North Platte
GSK Investigational Site, Little Rock
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Houston
GSK Investigational Site, Colorado Springs
GSK Investigational Site, Pueblo
GSK Investigational Site, Boise
GSK Investigational Site, West Jordan
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Phoenix
GSK Investigational Site, Mesa
GSK Investigational Site, Mesa
GSK Investigational Site, Chandler
GSK Investigational Site, Tempe
GSK Investigational Site, San Diego
GSK Investigational Site, San Diego
Lead Sponsor
GlaxoSmithKline
INDUSTRY